Award
National Cancer Institute 4R01CA294793-03
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH)
Award Amount
$2,082,604.00
Ceiling
$2,082,604.00
Awarded
June 25, 2026
Identifier
4R01CA294793-03
NIH-funded research project focused on identifying biomarkers and mechanisms of resistance to immunotherapy in brain metastases from breast cancer, using genomic and immunologic profiling and mouse models to explore combination therapies.
Description
This NIH-funded project aims to understand and overcome resistance to immunotherapy in CNS metastases of breast cancer, utilizing advanced genomic and immunologic profiling techniques, with potential to inform new treatment strategies.